ARHGAP9 and liver cancer: Ginsenoside Rg3 significantly inhibits the growth of a variety of liver cancer cell lines, including HepG2, SK-Hep1, MHCC-97L, MHCC-97H, SMMC-7721, and BEL-7404, and effectively inhibits the migration and invasion of liver cancer cells by upregulating ARHGAP9 protein expression (Sun et al., 2019).